Encompass Health Corp (AMEX:EHC) has been assigned an average recommendation of “Hold” from the fourteen research firms that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $53.63.
Several analysts have issued reports on EHC shares. SunTrust Banks set a $58.00 target price on Encompass Health and gave the company a “buy” rating in a research report on Thursday, December 21st. Royal Bank of Canada reaffirmed a “buy” rating on shares of Encompass Health in a research report on Wednesday, November 15th. Mizuho raised Encompass Health from a “neutral” rating to a “buy” rating and set a $55.00 target price on the stock in a research report on Thursday, November 2nd. Robert W. Baird reaffirmed a “buy” rating and set a $55.00 target price on shares of Encompass Health in a research report on Monday, October 9th. Finally, Zacks Investment Research raised Encompass Health from a “hold” rating to a “buy” rating and set a $52.00 target price on the stock in a research report on Monday, October 30th.
In other Encompass Health news, Director Yvonne M. Curl acquired 1,000 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The stock was purchased at an average price of $45.95 per share, for a total transaction of $45,950.00. Following the acquisition, the director now owns 64,144 shares in the company, valued at approximately $2,947,416.80. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company’s stock.
Encompass Health (AMEX EHC) opened at $52.43 on Friday. Encompass Health has a 52 week low of $38.24 and a 52 week high of $52.67. The stock has a market capitalization of $5,150.00, a P/E ratio of 19.14, a P/E/G ratio of 1.70 and a beta of 0.54. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.89.
Encompass Health (AMEX:EHC) last announced its earnings results on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.01. The business had revenue of $995.60 million for the quarter, compared to analysts’ expectations of $985.75 million. Encompass Health had a return on equity of 23.56% and a net margin of 8.67%. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.65 EPS. analysts expect that Encompass Health will post 2.72 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Friday, December 29th. This represents a $1.00 annualized dividend and a dividend yield of 1.91%. Encompass Health’s dividend payout ratio is presently 36.50%.
TRADEMARK VIOLATION NOTICE: This story was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/01/20/encompass-health-corp-ehc-given-average-rating-of-hold-by-analysts.html.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.